RQHTF (Reliq Health Technologies) Debt-to-EBITDA : -0.81 (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RQHTF Reliq Health Technologies Inc RQHTF
10 GF Score
Price $0.01
View Full Analysis

What is Reliq Health Technologies Debt-to-EBITDA?

Reliq Health Technologies RQHTF -99.99% 10 Debt-to-EBITDA is -0.81 as of Sep. 2022. GuruFocus rates RQHTF with a GF Score™ of 10/100.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Reliq Health Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.11 Mil. Reliq Health Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.11 Mil. Reliq Health Technologies's annualized EBITDA for the quarter that ended in Sep. 2022 was $-0.27 Mil. Reliq Health Technologies's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -0.81.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Reliq Health Technologies's Debt-to-EBITDA or its related term are showing as below:

RQHTF's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.25
* Ranked among companies with meaningful Debt-to-EBITDA only.

Reliq Health Technologies  (OTCPK:RQHTF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Reliq Health Technologies Debt-to-EBITDA Related Terms

Reliq Health Technologies Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Reliq Health Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reliq Health Technologies Debt-to-EBITDA Chart

Reliq Health Technologies Annual Data
Trend Dec13 Dec14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.04 -0.04 -0.04

Reliq Health Technologies Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.04 -0.11 -0.08 -0.81

RQHTF vs VEEV, GEHC, RCM: Debt-to-EBITDA Comparison

For the Health Information Services subindustry, Reliq Health Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reliq Health Technologies Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Reliq Health Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Reliq Health Technologies's Debt-to-EBITDA falls into.


RQHTF
10GF Score
Reliq Health Technologies Inc RQHTF
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reliq Health Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Reliq Health Technologies's Debt-to-EBITDA for the fiscal year that ended in Jun. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.095 + 0.144) / -6.264
=-0.04

Reliq Health Technologies's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.107 + 0.109) / -0.268
=-0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -0.81 mean?
Reliq Health Technologies (RQHTF) has a Debt-to-EBITDA of -0.81 as of Sep. 2022. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Reliq Health Technologies.
Is Reliq Health Technologies' Debt-to-EBITDA too high?
Reliq Health Technologies' current Debt-to-EBITDA is -0.81. Overall, Reliq Health Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Reliq Health Technologies' Debt-to-EBITDA compare to VEEV and GEHC?
Reliq Health Technologies' Debt-to-EBITDA of -0.81 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-EBITDA is 2.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Reliq Health Technologies. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reliq Health Technologies's current Debt-to-EBITDA is -0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reliq Health Technologies stock overvalued right now?
Reliq Health Technologies (RQHTF) has a current Debt-to-EBITDA of -0.81. The current Debt-to-EBITDA is -0.81. Reliq Health Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Reliq Health Technologies (RQHTF), the current Debt-to-EBITDA is -0.81 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reliq Health Technologies Business Description

Address 175 Longwood Rd S., Suite 406A, Hamilton, ON, CAN, L8P 0A1
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. The company's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.
10GF Score

Get the complete analysis for RQHTF

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price